terfenadine has been researched along with Myocardial Infarction in 2 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adebesin, AM | 1 |
Wesser, T | 1 |
Vijaykumar, J | 1 |
Konkel, A | 1 |
Paudyal, MP | 1 |
Lossie, J | 1 |
Zhu, C | 1 |
Westphal, C | 1 |
Puli, N | 1 |
Fischer, R | 1 |
Schunck, WH | 1 |
Falck, JR | 1 |
Gunawardena, MD | 1 |
Weerasinghe, A | 1 |
Herath, J | 1 |
Amarasena, N | 1 |
2 other studies available for terfenadine and Myocardial Infarction
Article | Year |
---|---|
Development of Robust 17(
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Arachidonic Acids; Dose-Response Relationship | 2019 |
Myocardial infarction associated with eosinophilia and plasma extravasation at multiple sites. A variant of Kounis syndrome.
Topics: Adult; Anti-Allergic Agents; Anti-Inflammatory Agents; Eosinophilia; Humans; Hypersensitivity, Immed | 2015 |